David A Stempel

Summary

Country: USA

Publications

  1. ncbi request reprint Patterns of asthma control: a 3-year analysis of patient claims
    David A Stempel
    Infomed Northwest and University of Washington, Seattle, USA
    J Allergy Clin Immunol 115:935-9. 2005
  2. ncbi request reprint Treatment patterns for pediatric asthma prior to and after emergency department events
    David A Stempel
    Infomed Northwest, Bellevue, Washington, USA
    Pediatr Pulmonol 40:310-5. 2005
  3. ncbi request reprint Adherence to asthma controller medication regimens
    D A Stempel
    Department of Pediatrics, Infomed Northwest and University of Washington, Bellevue, WA 98004, USA
    Respir Med 99:1263-7. 2005
  4. ncbi request reprint Treatment patterns in the months prior to and after asthma-related emergency department visit
    David A Stempel
    Infomed Northwest, Seattle, WA, USA
    Chest 126:75-80. 2004
  5. ncbi request reprint The pharmacologic management of childhood asthma
    David A Stempel
    Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98004, USA
    Pediatr Clin North Am 50:609-29. 2003
  6. ncbi request reprint Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma
    David A Stempel
    Infomed NW and University of Washington, Seattle, WA, USA
    Curr Med Res Opin 22:463-70. 2006
  7. ncbi request reprint The economic impact of children dispensed asthma medications without an asthma diagnosis
    David A Stempel
    Infomed Northwest Bellevue and University of Washington, Bellevue, Washington 98004, USA
    J Pediatr 148:819-23. 2006
  8. ncbi request reprint The use of rhinitis medications in children receiving initial controller therapy for asthma
    David A Stempel
    Infomed Northwest Bellevue, WA 98004, USA
    Curr Med Res Opin 22:2279-85. 2006
  9. ncbi request reprint Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast
    David A Stempel
    Infomed Northwest, Bellevue, WA, USA
    J Pediatr 150:162-7. 2007
  10. ncbi request reprint The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist
    David A Stempel
    University of Washington, Seattle, WA 98004, USA
    J Allergy Clin Immunol 110:39-41. 2002

Detail Information

Publications31

  1. ncbi request reprint Patterns of asthma control: a 3-year analysis of patient claims
    David A Stempel
    Infomed Northwest and University of Washington, Seattle, USA
    J Allergy Clin Immunol 115:935-9. 2005
    ..The goal of asthma therapy is to maintain consistent control...
  2. ncbi request reprint Treatment patterns for pediatric asthma prior to and after emergency department events
    David A Stempel
    Infomed Northwest, Bellevue, Washington, USA
    Pediatr Pulmonol 40:310-5. 2005
    ..In conclusion, this study demonstrates the dependence of children with asthma on the use of rescue medications. An ED event results in only an incremental and transient increase in ICS-containing controller treatment...
  3. ncbi request reprint Adherence to asthma controller medication regimens
    D A Stempel
    Department of Pediatrics, Infomed Northwest and University of Washington, Bellevue, WA 98004, USA
    Respir Med 99:1263-7. 2005
    ....
  4. ncbi request reprint Treatment patterns in the months prior to and after asthma-related emergency department visit
    David A Stempel
    Infomed Northwest, Seattle, WA, USA
    Chest 126:75-80. 2004
    ..This study was designed to describe the treatment patterns in the year prior to the ED event and for 2 months after the event...
  5. ncbi request reprint The pharmacologic management of childhood asthma
    David A Stempel
    Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98004, USA
    Pediatr Clin North Am 50:609-29. 2003
    ..Expectations should be high. Concerns about the potential for adverse effects should always be addressed proactively and should be balanced with the potential of adverse events from the disease...
  6. ncbi request reprint Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma
    David A Stempel
    Infomed NW and University of Washington, Seattle, WA, USA
    Curr Med Res Opin 22:463-70. 2006
    ....
  7. ncbi request reprint The economic impact of children dispensed asthma medications without an asthma diagnosis
    David A Stempel
    Infomed Northwest Bellevue and University of Washington, Bellevue, Washington 98004, USA
    J Pediatr 148:819-23. 2006
    ..To compare the resource utilization and healthcare costs of children with a diagnosis of asthma, children dispensed asthma medications but without a diagnosis of asthma, and control children...
  8. ncbi request reprint The use of rhinitis medications in children receiving initial controller therapy for asthma
    David A Stempel
    Infomed Northwest Bellevue, WA 98004, USA
    Curr Med Res Opin 22:2279-85. 2006
    ..Due to common features of asthma and allergic rhinitis, a single therapeutic approach to treating both of these conditions has been proposed...
  9. ncbi request reprint Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast
    David A Stempel
    Infomed Northwest, Bellevue, WA, USA
    J Pediatr 150:162-7. 2007
    ..To assess the comparative efficacy of fluticasone propionate (FP) and montelukast (MON), using administrative claims for pediatric asthma in a clinical setting...
  10. ncbi request reprint The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist
    David A Stempel
    University of Washington, Seattle, WA 98004, USA
    J Allergy Clin Immunol 110:39-41. 2002
    ..Considered in aggregate, the data support the conclusion that leukotriene modifiers should not be substituted for inhaled corticosteroids as a single-controller therapy for asthma...
  11. ncbi request reprint Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs
    David A Stempel
    Virginia Mason Clinic, Seattle, WA 98101, USA
    J Allergy Clin Immunol 109:433-9. 2002
    ..Observational research from real-world clinical practice is needed to confirm these results...
  12. ncbi request reprint Approaching value in asthma management: the need to integrate clinical and economic research with the basic science
    David A Stempel
    Virginia Mason Medical Center, 1100 Ninth Avenue, Seattle, WA 98101, USA
    J Allergy Clin Immunol 109:S503-10. 2002
    ..Taken together, the results of such analyses form a foundation for providing effective, safe, and cost-efficient care through the practice of evidence-based medicine...
  13. ncbi request reprint The cost of treating allergic rhinitis
    David A Stempel
    Virginia Mason Clinic, Virginia Mason Medical Center, 1100 Ninth Avenue, Seattle, WA 98004, USA
    Curr Allergy Asthma Rep 2:223-30. 2002
    ..INCS have lower average wholesale prices as a class than the NSAH. Since the INCS are the dominant medication in efficacy studies and cost less, cost-effectiveness studies always favor intranasal corticosteroids...
  14. ncbi request reprint Single-inhaler combination therapy for asthma: a review of cost effectiveness
    Manabu Akazawa
    Department of Health Policy and Administration, School of Public Health, University of North Carolina at Chapel Hill, North Carolina, USA
    Pharmacoeconomics 24:971-88. 2006
    ..Further considerations for measuring long-term outcomes and dose-response relationships might be required to provide further evidence on the cost effectiveness of combination therapy with ICS plus LABA...
  15. ncbi request reprint Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens
    Richard D O'Connor
    Sharp Rees Stealy Medical Group, San Diego, California, USA
    Ann Allergy Asthma Immunol 95:535-40. 2005
    ..Asthma control is the goal of therapeutic interventions. In observational studies, the use of short-acting beta-agonists (SABAs) is a surrogate for symptoms and emergency department or hospital events for exacerbations...
  16. ncbi request reprint The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices
    B Gwen Carlton
    J Asthma 42:529-35. 2005
    ..As a result of the assessment of the patients' level of asthma control during the office visit, physicians changed their patterns of prescribing controller therapy in patients with uncontrolled asthma...
  17. doi request reprint Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma
    Thomas E Delea
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 30:560-71. 2008
    ....
  18. ncbi request reprint The myth of mild asthma
    David A Stempel
    Ann Allergy Asthma Immunol 89:340-3. 2002
  19. ncbi request reprint Study design is a major determinant of whether equivalence or superiority is demonstrated
    Stuart W Stoloff
    J Allergy Clin Immunol 111:1413; author reply 1413-4. 2003
  20. ncbi request reprint Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies
    Stuart W Stoloff
    University of Nevada School of Medicine, Reno, Nev, USA
    J Allergy Clin Immunol 113:245-51. 2004
    ..Improved adherence to inhaled corticosteroids (ICSs) has also been associated with decreased asthma-associated morbidity and mortality...
  21. ncbi request reprint Exhaled nitric oxide
    David A Stempel
    Ann Allergy Asthma Immunol 92:381; author reply 381-2. 2004
  22. ncbi request reprint The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes
    William E Berger
    American College of Allergy, Asthma, and Immunology, Mission Viejo, California, USA
    Ann Allergy Asthma Immunol 93:538-45. 2004
    ..The Health Plan Employer Data and Information Set (HEDIS) measures are used extensively to measure quality of care...
  23. ncbi request reprint September epidemic of asthma exacerbations in children: a manifestation of persistent or episodic disease?
    David A Stempel
    J Allergy Clin Immunol 115:230-2. 2005
  24. ncbi request reprint Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations
    Trudy B Pendergraft
    GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA
    Ann Allergy Asthma Immunol 93:29-35. 2004
    ..A life-threatening attack of asthma that leads to intensive care unit (ICU) admission, intubation, or both identifies patients at high risk of subsequent morbidity and mortality and represents a major cost burden...
  25. ncbi request reprint Foreword
    Homer A Boushey
    Department of Allergy and Immunology, Asthma Clinical Research Center, University of California San Francisco, 515 Parnassus Avenue, Room M192, San Francisco, CA 94143, USA
    J Allergy Clin Immunol 109:S479-81. 2002
  26. ncbi request reprint Asthma: addressing consistency in results from basic science, clinical trials, and observational experience
    Joseph Spahn
    National Jewish Medical and Research Center, University of Colorado, School of Medicine, Denver, CO, USA
    J Allergy Clin Immunol 109:S490-502. 2002
    ..These analyses have confirmed that initial treatment with inhaled corticosteroids and combined treatment with inhaled corticosteroids and long-acting bronchodilators are the most effective stepwise approaches to the treatment of asthma...
  27. ncbi request reprint Assessing the impact of asthma guideline implementation
    David A Stempel
    Chest 130:5-6. 2006
  28. ncbi request reprint Assessing the economic burden of asthma
    David A Stempel
    J Allergy Clin Immunol 111:1203-4. 2003
  29. ncbi request reprint Seasonal variation in asthma-related hospital and intensive care unit admissions
    Trudy B Pendergraft
    GlaxoSmithKline, RTP, North Carolina 27709, USA
    J Asthma 42:265-71. 2005
    ..These findings suggest a need for year-round vigilance and improved compliance with asthma therapy, especially during the summer when asthma attacks are perceived to be infrequent...
  30. ncbi request reprint Assessment of asthma control in a general population of asthmatics
    Michael Lenoir
    Associate Clinical Professor, Pediatrics University of California, San Francisco, Oakland, CA, USA
    Curr Med Res Opin 22:17-22. 2006
    ..Asthma control is typically assessed by review of symptoms and measurement of airflow obstruction by clinic spirometry or outpatient peak flow. Recently the role of questionnaires to assess asthma control has been discussed...
  31. ncbi request reprint Defining the responder in asthma therapy
    David A Stempel
    J Allergy Clin Immunol 115:466-9. 2005